The LPH system demonstrated sustained release of the cancer-targeting peptide over a two-week period, enhanced uptake by immune cells, activated immune cells called antigen-presenting cells by ...
In contrast, BioVaxys’ DPX platform employs a non-aqueous, lipid-in-oil formulation that maintains the antigen at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback